Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study

Grants

Funding Acknowledgements

This study was supported by Merck Serono S.A. - Geneva, Switzerland (a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany), and by institutional grants from the French 2009 Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie, Grant number: IRESP 2009 - PreSP0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors retained full control over the content of the manuscript. We thank all the investigators of the study.